The Ultimate Fighting Championship signed a deal with the United States Anti-Doping Agency (USADA) to help clean the sport of mixed martial arts and rid the octagon of performance enhancing drugs. Fighters who are on the active UFC roster are subjected to random drug tests, and George Sullivan has been flagged for another potential drug test violation.
Sullivan was just wrapping up a suspension that was dealt to him by USADA last year for testing positive for Insulin Growth Factor -1 (IGF-1), a banned substance. He was set to finish his suspension on January 31, 2017 where he would go on to compete at “UFC 208” but this new violation will keep him from stepping into the octagon. UFC released the following statement here which you can read below:
“Sullivan is currently serving a one year suspension under the UFC Anti-Doping Program, for his use of a product containing the prohibited substance Insulin Growth Factor -1 (IGF-1). Sullivan was due to end his current suspension on January 31, 2017, and compete on the UFC 208 card in Brooklyn, New York, against Randy Brown. However, USADA has provisionally suspended Sullivan based on the new potential anti-doping violation, and the UFC has removed Sullivan from the UFC 208 card. The UFC is currently seeking a replacement to face Randy Brown.”